血管紧张素受体-奈普利素抑制与急性心肌梗死的ACE抑制

H. Krumholz, Sm
{"title":"血管紧张素受体-奈普利素抑制与急性心肌梗死的ACE抑制","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54253","DOIUrl":null,"url":null,"abstract":"Is the angiotensin receptor–neprilysin inhibitor sacubitril–valsartan superior to the angiotensin-converting–enzyme (ACE) inhibitor ramipril in","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Angiotensin Receptor–Neprilysin Inhibition vs. ACE Inhibition in Acute Myocardial Infarction\",\"authors\":\"H. Krumholz, Sm\",\"doi\":\"10.1056/NEJM-JW.NA54253\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Is the angiotensin receptor–neprilysin inhibitor sacubitril–valsartan superior to the angiotensin-converting–enzyme (ACE) inhibitor ramipril in\",\"PeriodicalId\":19048,\"journal\":{\"name\":\"NEJM Journal Watch\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NEJM Journal Watch\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1056/NEJM-JW.NA54253\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NEJM Journal Watch","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1056/NEJM-JW.NA54253","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

血管紧张素受体- neprilysin抑制剂sacubitil - valsartan是否优于血管紧张素转换酶(ACE)抑制剂雷米普利
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Angiotensin Receptor–Neprilysin Inhibition vs. ACE Inhibition in Acute Myocardial Infarction
Is the angiotensin receptor–neprilysin inhibitor sacubitril–valsartan superior to the angiotensin-converting–enzyme (ACE) inhibitor ramipril in
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Another Monoclonal Therapy Option for Early COVID-19 Further Evidence to Support a Low-Sodium, High-Potassium Diet Longer-Term Follow-Up in Patients Receiving AAV Gene Therapy for Hemophilia A Influenza Vaccination in Children: Recommendations for the 2021–2022 Season PCI vs. CABG for Left Main Coronary Artery Disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1